Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group Block Versus Interscalene Brachial Plexus Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries
Launched by AIN SHAMS UNIVERSITY · Jan 8, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different ways to manage pain after shoulder surgeries. Researchers want to find out which method works best among three options: the Anterior Glenoid Nerve Block, the Pericapsular Nerve Group Block, and the Interscalene Brachial Plexus Block. All of these methods involve injecting anesthetic near nerves to help reduce pain after surgery. The trial is currently looking for participants aged 18 to 70 who are scheduled for shoulder arthroscopic surgeries and are in good health (specifically, those with an American Society of Anesthesiology status of I or II).
If you join the study, you will receive one of these pain management techniques during your surgery, and the researchers will monitor your recovery and pain levels afterward. It's important to note that you cannot participate if you have certain conditions, like a history of severe drug allergies, local infections, or previous shoulder surgeries. This trial aims to improve pain management options for patients undergoing similar surgeries, making recovery easier and more comfortable for everyone involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age from 18 to 70 years.
- • No sex predilection.
- • American Society of Anesthesiology (ASA) physical status I-II.
- • Undergoing shoulder arthroscopic surgeries.
- Exclusion Criteria:
- • Patient's refusal.
- • Patients with a history of drug allergies to study drugs.
- • Evidence of local infection at the site of injection.
- • Inability to cooperate
- • Neuromuscular pathology (example: - Multiple Sclerosis)
- • Previous trauma or surgery to the shoulder
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported